| Beamline 5.0.1 |
|
|
|
|
|
|
| |
|
|
|
|
| December 2008 |
|
|
|
|
| |
|
Organization |
Scheduled Time |
# Shifts |
PI |
User Contact |
| |
|
|
|
|
| 1 |
Monday |
|
|
|
|
|
|
| |
|
|
|
|
| 2 |
Tuesday |
Gilead |
2pm-9am |
2 |
McGrath |
|
| 3 |
Wednesday |
Amgen /
*Takeda |
10am - 9am (2) |
3 |
Jordan |
|
| 4 |
Thursday |
TBSGX *Staff/Taylor |
10am - 9am |
3 |
Hung Taylor |
Yu |
| 5 |
Friday |
NIH |
Staff TBD |
10am - 9am (1) |
3 |
|
|
| 6 |
Saturday |
GlaxoSmithKline CC-Banu |
10am - 9am |
3 |
Williams Banu |
|
| 7 |
Sunday |
Staff *Scripps-Chang*LBNL |
10am - 8am |
3 |
Chang |
Pereira |
| |
|
|
|
|
|
| 8 |
Monday |
|
|
|
|
|
|
| |
|
|
|
|
| 9 |
Tuesday |
Vertex *Staff |
2pm-9am |
2 |
Jacobs |
|
| 10 |
Wednesday |
Genentech |
10am - 9am |
3 |
Eigenbrot |
|
| 11 |
Thursday |
Decode |
10am - 9am |
3 |
Staker |
|
| 12 |
Friday |
U OregonVertex |
Pacific Bio |
10am - 9am (1) |
3 |
Berglund/He |
Zwart |
| 13 |
Saturday |
USC |
10am - 8am |
3 |
Chen |
|
| |
|
|
|
|
|
| 14 |
Sunday |
|
|
|
|
|
|
| 15 |
Monday |
|
|
|
|
| 16 |
Tuesday |
|
|
|
|
|
|
| |
|
|
|
|
| 17 |
Wednesday |
Novartis E |
2pm-9am |
2 |
Bussiere |
|
| 18 |
Thursday |
Amgen *Staff |
10am - 9am |
3 |
Jordan |
|
| 19 |
Friday |
Celgene |
10am - 9am |
3 |
Nowakowski |
|
| 20 |
Saturday |
Staff TBD |
10am - 9am |
3 |
|
|
| 21 |
Sunday |
Decode *Staff |
10am - 9am |
3 |
Edwards |
|
| 22 |
Monday |
Staff *Decode |
10am - 9am |
3 |
|
|
| 23 |
Tuesday |
Staff TBD |
10am - 11pm |
2 |
|
|
| |
|
|
|
|
|
| 24 |
Wednesday |
|
|
|
|
|
|
| 25 |
Thursday |
|
|
W |
B |
|
|
| 26 |
Friday |
|
|
I |
R |
|
|
| 27 |
Saturday |
|
|
N |
E |
|
|
| 28 |
Sunday |
|
|
T |
A |
|
|
| 29 |
Monday |
|
|
E |
K |
|
|
| 30 |
Tuesday |
|
|
R |
|
|
|
| 31 |
Wednesday |
|
|
|
|
|
|
| |
|
|
|
|
| |
Legend |
|
|
|
|
|
|
| |
|
PRT (SC=Service Crystallography) |
|
(1)
First user 10am-1:30am; Second user
1:30am-9am |
| |
|
GU |
|
(2)
Amgen 10am-5:30pm; Takeda 5:30pm-9am |
| |
|
Staff |
|
|
| |
|
No Beamtime |
|
50 |
shifts |
|
| |
* Non PRT's scheduled on
canceled or unused beamtime |
|
|
|
|
|
|
|
|
|
|
|
|